Litcius/Paper detail

Ocrelizumab: A Review in Multiple Sclerosis

Yvette N. Lamb

2022Drugs130 citationsDOIOpen Access PDF

Topics & Concepts

OcrelizumabMedicineMultiple sclerosisClinical trialPlaceboInternal medicineOfatumumabCD20OncologyImmunologyRituximabPathologyLymphomaAlternative medicineMultiple Sclerosis Research StudiesRheumatoid Arthritis Research and TherapiesPeripheral Neuropathies and Disorders
Ocrelizumab: A Review in Multiple Sclerosis | Litcius